期刊文献+

开发微生物来源天然产物的新技术 被引量:3

The Methods of Exploiting the Natural Products of Microbes
在线阅读 下载PDF
导出
摘要 微生物在药物的开发中具有十分重要的作用,主要表现在微生物的次级代谢产物具有结构多样性、活性广泛性和临床有效性,其中许多化合物或其衍生物已经成为临床治疗多种疾病的药物。开发微生物来源的天然产物包括寻找新资源和革新新技术。本文介绍微生物药物的优点和局限性,获得更多微生物资源的途径以及微生物药物研发中5种新技术的应用,并探讨了各自的局限性。 Microorganisms play an important role in drug development, as their metabolites show a great diversity of chemical structures, broad range of anti-bacterial spectrum and clinical efficacy. Many of them and their derivatives have been developed into drugs for the treatment of various diseases. The strategies of exploring new natural products from microbes involve searching for new microbial resources and innovating techniques used in drug research. This article introduces both advantages and disadvantages of the drugs derived from microbial resources, the methods used for exploring more microbial resources and the applications of five widely used new techniques.
作者 武英 王辂
出处 《国外医药(抗生素分册)》 CAS 2010年第1期1-6,12,共7页 World Notes on Antibiotics
关键词 突变生物合成 组合生物合成 生物转化 宏基因组 DNA改组 mutational biosynthesis combinatorial biosynthesis biotransformation metagenome DNA shuffling
  • 相关文献

参考文献38

  • 1于德泉.从天然产物创制新药的发展趋势[J].中国工程科学,1999,1(2):87-90. 被引量:8
  • 2Baker D.The value of natural products to future pharmaceutical discovery[J]. Nat Prod Rep, 2007, 24:1225.
  • 3Newman D J, Cragg GM. Natural products as sources of new drugs over the last 25 years[J]. J Nat Prod, 2007,70:461.
  • 4Ganesan A.The impact of natural products upon modern drug discovery[J]. Curr Opin Chem Biol, 2008,12, 306.
  • 5Butler MS. Natural products to drugs: natural productderived compounds in clinical trials[J]. Nat Prod Rep, 2008, 25:475.
  • 6Ganesan A. The impact of natural products upon modern drug discovery[J]. Curr Opin Chem Biol, 2008,12(3):306.
  • 7Grabowski K, Schneider G. Properties and architecture of drugs and natural products revisited[J]. Curr Chem Biol, 2007, 1:115.
  • 8Charlish P. Traditional remedies: latter day medicines[J]. Scrip World Pharm News, 2008, 3351:31.
  • 9Galm U, Shen B. Natural product drug discovery: the times have never been better[J]. Chem Biol, 2007, 14: 1098.
  • 10Janos Berdy. Bioactive Microbial Metabolites[J]. J Antibiot, 2005, 58:1.

二级参考文献54

  • 1陈林,刘家健.氨基糖苷类抗生素的新研究动向[J].国外医药(抗生素分册),2005,26(2):86-91. 被引量:3
  • 2赵敏,范瑾,胡小玲,谢凤龙,刘军,汪洁,杨晓伟.庆大霉素C_(1a)单组份产生菌─—棘孢小单孢菌JIM-202的筛选和研究[J].中国抗生素杂志,1997,22(1):12-15. 被引量:13
  • 3全球华人中药现代化学术研讨会论文集,1998年
  • 4Scholar E M, Pratt W B. The Antimicrobial drugs [M]. Second edition. New York: Oxford University Press Inc, 2004:127.
  • 5Dax S L. Aminoglycoside antibiotics [A]. In:Antibacterial chemotherapeutic agents [M]. London: Blackie Acadamic & Professional, 1997 : 207.
  • 6Boehr D D, Draker K A, Koteva K, et al. Broad-spectrum peptide inhibitors of aminoglycoside antibiotic resistance enzymes [J]. Chem Biol,2003,10(2) : 189.
  • 7Llano-Sotelo B, Azucena E F Jr, Kotra L P, et al. Aminoglyeosides modified by resistance enzymes display diminished binding to the bacterial ribosomal aminoaeyl-tRNA site [[J]. Chem Biol,2002,9(4):455.
  • 8Matsuo H, Kobayashi M, Kumagai T, et al. Molecular mechanism for the enhancement of arbekacin resistance in a methicillin-resistant Staphylococcus aureus [J]. FEBS Lett,2003,546(2-3) :401.
  • 9del Campo R, Tenorio C, Rubio C, et al. Aminoglycoside-modifying enzymes in high-level streptomycin and gentamiein resistant Enterococcus spp. in Spain [J]. Int J A ntimicrob Agents, 2000,15 (3) : 221.
  • 10Sullivan J M, Goodisman J, Dabrowiak J C. Absorption studies on aminoglyeoside binding to the packaging region of human immunodefieieney virus type-1 [J]. Bioorg Med Chem Lett ,2002,12(4) : 615.

共引文献13

同被引文献42

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部